{"id":39562,"date":"2023-01-05T17:35:18","date_gmt":"2023-01-05T20:35:18","guid":{"rendered":"https:\/\/insurancecorp.com.br\/pt\/?p=39562"},"modified":"2023-01-05T17:37:08","modified_gmt":"2023-01-05T20:37:08","slug":"novo-tratamento-contra-covid-1-e-aprovado-no-brasil","status":"publish","type":"post","link":"https:\/\/insurancecorp.com.br\/pt\/2023\/01\/05\/novo-tratamento-contra-covid-1-e-aprovado-no-brasil\/","title":{"rendered":"Novo tratamento contra covid-1 \u00e9 aprovado no Brasil"},"content":{"rendered":"<p>Uma nova terapia obteve aprova\u00e7\u00e3o pela Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (ANVISA) para o tratamento da covid-19<sup>1<\/sup>. Trata-se de uma combina\u00e7\u00e3o dos anticorpos monoclonais cilgavimabe e tixagevimabe, da AstraZeneca, e que j\u00e1 tinha indica\u00e7\u00e3o para preven\u00e7\u00e3o de casos graves em pacientes n\u00e3o infectados e sem contato pr\u00e9vio com o v\u00edrus (profilaxia pr\u00e9-exposi\u00e7\u00e3o).<\/p>\n<p>Agora, o tratamento passa a ser recomendado para pacientes com diagn\u00f3stico de covid-19 que n\u00e3o necessitam de oxig\u00eanio suplementar e que demonstrem risco aumentado de progress\u00e3o para o estado grave da doen\u00e7a, ampliando o arsenal de combate \u00e0 pandemia \u00e0s v\u00e9speras das festas de Natal e Ano Novo, quando h\u00e1 risco de acelerar a alta de cont\u00e1gios registrada desde o in\u00edcio de dezembro. A aprova\u00e7\u00e3o ocorreu por unanimidade pela Diretoria Colegiada da ANVISA, no \u00faltimo dia 16 de dezembro.<\/p>\n<p>O medicamento \u00e9 indicado para pacientes com idade a partir de 12 anos (com peso m\u00ednimo de 40 Kg), que apresentem sintomas leves por at\u00e9 sete dias e tenham risco aumentado de evoluir para quadros mais graves da doen\u00e7a<sup>1<\/sup>. Idade avan\u00e7ada, imunossuprimidos por tratamento contra c\u00e2ncer ou pessoas que tenham realizado transplante recente de \u00f3rg\u00e3os fazem parte do grupo.<\/p>\n<p>&#8220;De uso ambulatorial, com aplica\u00e7\u00e3o intramuscular em dose \u00fanica, o tratamento reduz entre 80% e 90% os casos de hospitaliza\u00e7\u00e3o e \u00f3bito para as variantes suscet\u00edveis ao medicamento&#8221;, destaca a diretora M\u00e9dica da AstraZeneca Brasil, doutora Marina Belhaus. A indica\u00e7\u00e3o \u00e9 v\u00e1lida inclusive para pacientes que estejam com o ciclo vacinal completo.<\/p>\n<p>A terapia j\u00e1 est\u00e1 aprovada em outros pa\u00edses, como Estados Unidos, Fran\u00e7a, Israel, It\u00e1lia, Egito e Emirados \u00c1rabes Unidos.<\/p>\n<p>Apesar da novidade, especialistas refor\u00e7am a import\u00e2ncia de medidas para prevenir a infec\u00e7\u00e3o, como uso de m\u00e1scaras, especialmente em locais de aglomera\u00e7\u00e3o, e \u00e1lcool em gel para higieniza\u00e7\u00e3o das m\u00e3os, al\u00e9m das doses de refor\u00e7o da vacina.<\/p>\n<p><strong>Assessoria de Imprensa AstraZeneca<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Uma nova terapia obteve aprova\u00e7\u00e3o pela Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (ANVISA) para o tratamento da covid-191. Trata-se de uma combina\u00e7\u00e3o dos anticorpos monoclonais cilgavimabe e tixagevimabe, da AstraZeneca, e que j\u00e1 tinha indica\u00e7\u00e3o para preven\u00e7\u00e3o de casos graves em pacientes n\u00e3o infectados e sem contato pr\u00e9vio com o v\u00edrus (profilaxia pr\u00e9-exposi\u00e7\u00e3o). Agora, o tratamento [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":39564,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[31],"tags":[6518,2395,854,6179,828],"class_list":["post-39562","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-interesse-publico","tag-aprovado","tag-brasil","tag-covid-19","tag-novo","tag-tratamento"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Novo tratamento contra covid-1 \u00e9 aprovado no Brasil | Revista Insurance Corp | PT-BR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/insurancecorp.com.br\/pt\/2023\/01\/05\/novo-tratamento-contra-covid-1-e-aprovado-no-brasil\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Novo tratamento contra covid-1 \u00e9 aprovado no Brasil | Revista Insurance Corp | PT-BR\" \/>\n<meta property=\"og:description\" content=\"Uma nova terapia obteve aprova\u00e7\u00e3o pela Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (ANVISA) para o tratamento da covid-191. Trata-se de uma combina\u00e7\u00e3o dos anticorpos monoclonais cilgavimabe e tixagevimabe, da AstraZeneca, e que j\u00e1 tinha indica\u00e7\u00e3o para preven\u00e7\u00e3o de casos graves em pacientes n\u00e3o infectados e sem contato pr\u00e9vio com o v\u00edrus (profilaxia pr\u00e9-exposi\u00e7\u00e3o). Agora, o tratamento [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/insurancecorp.com.br\/pt\/2023\/01\/05\/novo-tratamento-contra-covid-1-e-aprovado-no-brasil\/\" \/>\n<meta property=\"og:site_name\" content=\"Revista Insurance Corp | PT-BR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RevistaInsuranceCorp\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-05T20:35:18+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-01-05T20:37:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/i0.wp.com\/insurancecorp.com.br\/pt\/wp-content\/uploads\/2023\/01\/A1-12-scaled.jpg?fit=2560%2C1440&ssl=1\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1440\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Publica\u00e7\u00e3o\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Publica\u00e7\u00e3o\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/2023\\\/01\\\/05\\\/novo-tratamento-contra-covid-1-e-aprovado-no-brasil\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/2023\\\/01\\\/05\\\/novo-tratamento-contra-covid-1-e-aprovado-no-brasil\\\/\"},\"author\":{\"name\":\"Publica\u00e7\u00e3o\",\"@id\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/#\\\/schema\\\/person\\\/1b69c8cf325f0b7167f1b171f52df4af\"},\"headline\":\"Novo tratamento contra covid-1 \u00e9 aprovado no Brasil\",\"datePublished\":\"2023-01-05T20:35:18+00:00\",\"dateModified\":\"2023-01-05T20:37:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/2023\\\/01\\\/05\\\/novo-tratamento-contra-covid-1-e-aprovado-no-brasil\\\/\"},\"wordCount\":345,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/2023\\\/01\\\/05\\\/novo-tratamento-contra-covid-1-e-aprovado-no-brasil\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/wp-content\\\/uploads\\\/2023\\\/01\\\/A1-12-scaled.jpg\",\"keywords\":[\"aprovado\",\"Brasil\",\"covid-19\",\"novo\",\"tratamento\"],\"articleSection\":[\"Interesse P\u00fablico\"],\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/2023\\\/01\\\/05\\\/novo-tratamento-contra-covid-1-e-aprovado-no-brasil\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/2023\\\/01\\\/05\\\/novo-tratamento-contra-covid-1-e-aprovado-no-brasil\\\/\",\"url\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/2023\\\/01\\\/05\\\/novo-tratamento-contra-covid-1-e-aprovado-no-brasil\\\/\",\"name\":\"Novo tratamento contra covid-1 \u00e9 aprovado no Brasil | Revista Insurance Corp | PT-BR\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/2023\\\/01\\\/05\\\/novo-tratamento-contra-covid-1-e-aprovado-no-brasil\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/2023\\\/01\\\/05\\\/novo-tratamento-contra-covid-1-e-aprovado-no-brasil\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/wp-content\\\/uploads\\\/2023\\\/01\\\/A1-12-scaled.jpg\",\"datePublished\":\"2023-01-05T20:35:18+00:00\",\"dateModified\":\"2023-01-05T20:37:08+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/2023\\\/01\\\/05\\\/novo-tratamento-contra-covid-1-e-aprovado-no-brasil\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/2023\\\/01\\\/05\\\/novo-tratamento-contra-covid-1-e-aprovado-no-brasil\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/2023\\\/01\\\/05\\\/novo-tratamento-contra-covid-1-e-aprovado-no-brasil\\\/#primaryimage\",\"url\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/wp-content\\\/uploads\\\/2023\\\/01\\\/A1-12-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/wp-content\\\/uploads\\\/2023\\\/01\\\/A1-12-scaled.jpg\",\"width\":2560,\"height\":1440},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/2023\\\/01\\\/05\\\/novo-tratamento-contra-covid-1-e-aprovado-no-brasil\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Novo tratamento contra covid-1 \u00e9 aprovado no Brasil\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/#website\",\"url\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/\",\"name\":\"Revista Insurance Corp | PT-BR\",\"description\":\"A \u00fanica revista bil\u00edngue voltada ao mercado de seguro.\",\"publisher\":{\"@id\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/#organization\",\"name\":\"Revista Insurance Corp\",\"url\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Revista Insurance Corp\"},\"image\":{\"@id\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/RevistaInsuranceCorp\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/#\\\/schema\\\/person\\\/1b69c8cf325f0b7167f1b171f52df4af\",\"name\":\"Publica\u00e7\u00e3o\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0a30cecf8e1b3673b68620de9f9a164e8f9cce0e15f8e36bcff0e4a33c0142e8?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0a30cecf8e1b3673b68620de9f9a164e8f9cce0e15f8e36bcff0e4a33c0142e8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0a30cecf8e1b3673b68620de9f9a164e8f9cce0e15f8e36bcff0e4a33c0142e8?s=96&d=mm&r=g\",\"caption\":\"Publica\u00e7\u00e3o\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Novo tratamento contra covid-1 \u00e9 aprovado no Brasil | Revista Insurance Corp | PT-BR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/insurancecorp.com.br\/pt\/2023\/01\/05\/novo-tratamento-contra-covid-1-e-aprovado-no-brasil\/","og_locale":"pt_BR","og_type":"article","og_title":"Novo tratamento contra covid-1 \u00e9 aprovado no Brasil | Revista Insurance Corp | PT-BR","og_description":"Uma nova terapia obteve aprova\u00e7\u00e3o pela Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (ANVISA) para o tratamento da covid-191. Trata-se de uma combina\u00e7\u00e3o dos anticorpos monoclonais cilgavimabe e tixagevimabe, da AstraZeneca, e que j\u00e1 tinha indica\u00e7\u00e3o para preven\u00e7\u00e3o de casos graves em pacientes n\u00e3o infectados e sem contato pr\u00e9vio com o v\u00edrus (profilaxia pr\u00e9-exposi\u00e7\u00e3o). Agora, o tratamento [&hellip;]","og_url":"https:\/\/insurancecorp.com.br\/pt\/2023\/01\/05\/novo-tratamento-contra-covid-1-e-aprovado-no-brasil\/","og_site_name":"Revista Insurance Corp | PT-BR","article_publisher":"https:\/\/www.facebook.com\/RevistaInsuranceCorp\/","article_published_time":"2023-01-05T20:35:18+00:00","article_modified_time":"2023-01-05T20:37:08+00:00","og_image":[{"width":2560,"height":1440,"url":"https:\/\/i0.wp.com\/insurancecorp.com.br\/pt\/wp-content\/uploads\/2023\/01\/A1-12-scaled.jpg?fit=2560%2C1440&ssl=1","type":"image\/jpeg"}],"author":"Publica\u00e7\u00e3o","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Publica\u00e7\u00e3o","Est. tempo de leitura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/insurancecorp.com.br\/pt\/2023\/01\/05\/novo-tratamento-contra-covid-1-e-aprovado-no-brasil\/#article","isPartOf":{"@id":"https:\/\/insurancecorp.com.br\/pt\/2023\/01\/05\/novo-tratamento-contra-covid-1-e-aprovado-no-brasil\/"},"author":{"name":"Publica\u00e7\u00e3o","@id":"https:\/\/insurancecorp.com.br\/pt\/#\/schema\/person\/1b69c8cf325f0b7167f1b171f52df4af"},"headline":"Novo tratamento contra covid-1 \u00e9 aprovado no Brasil","datePublished":"2023-01-05T20:35:18+00:00","dateModified":"2023-01-05T20:37:08+00:00","mainEntityOfPage":{"@id":"https:\/\/insurancecorp.com.br\/pt\/2023\/01\/05\/novo-tratamento-contra-covid-1-e-aprovado-no-brasil\/"},"wordCount":345,"commentCount":0,"publisher":{"@id":"https:\/\/insurancecorp.com.br\/pt\/#organization"},"image":{"@id":"https:\/\/insurancecorp.com.br\/pt\/2023\/01\/05\/novo-tratamento-contra-covid-1-e-aprovado-no-brasil\/#primaryimage"},"thumbnailUrl":"https:\/\/insurancecorp.com.br\/pt\/wp-content\/uploads\/2023\/01\/A1-12-scaled.jpg","keywords":["aprovado","Brasil","covid-19","novo","tratamento"],"articleSection":["Interesse P\u00fablico"],"inLanguage":"pt-BR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/insurancecorp.com.br\/pt\/2023\/01\/05\/novo-tratamento-contra-covid-1-e-aprovado-no-brasil\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/insurancecorp.com.br\/pt\/2023\/01\/05\/novo-tratamento-contra-covid-1-e-aprovado-no-brasil\/","url":"https:\/\/insurancecorp.com.br\/pt\/2023\/01\/05\/novo-tratamento-contra-covid-1-e-aprovado-no-brasil\/","name":"Novo tratamento contra covid-1 \u00e9 aprovado no Brasil | Revista Insurance Corp | PT-BR","isPartOf":{"@id":"https:\/\/insurancecorp.com.br\/pt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/insurancecorp.com.br\/pt\/2023\/01\/05\/novo-tratamento-contra-covid-1-e-aprovado-no-brasil\/#primaryimage"},"image":{"@id":"https:\/\/insurancecorp.com.br\/pt\/2023\/01\/05\/novo-tratamento-contra-covid-1-e-aprovado-no-brasil\/#primaryimage"},"thumbnailUrl":"https:\/\/insurancecorp.com.br\/pt\/wp-content\/uploads\/2023\/01\/A1-12-scaled.jpg","datePublished":"2023-01-05T20:35:18+00:00","dateModified":"2023-01-05T20:37:08+00:00","breadcrumb":{"@id":"https:\/\/insurancecorp.com.br\/pt\/2023\/01\/05\/novo-tratamento-contra-covid-1-e-aprovado-no-brasil\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/insurancecorp.com.br\/pt\/2023\/01\/05\/novo-tratamento-contra-covid-1-e-aprovado-no-brasil\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/insurancecorp.com.br\/pt\/2023\/01\/05\/novo-tratamento-contra-covid-1-e-aprovado-no-brasil\/#primaryimage","url":"https:\/\/insurancecorp.com.br\/pt\/wp-content\/uploads\/2023\/01\/A1-12-scaled.jpg","contentUrl":"https:\/\/insurancecorp.com.br\/pt\/wp-content\/uploads\/2023\/01\/A1-12-scaled.jpg","width":2560,"height":1440},{"@type":"BreadcrumbList","@id":"https:\/\/insurancecorp.com.br\/pt\/2023\/01\/05\/novo-tratamento-contra-covid-1-e-aprovado-no-brasil\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/insurancecorp.com.br\/pt\/"},{"@type":"ListItem","position":2,"name":"Novo tratamento contra covid-1 \u00e9 aprovado no Brasil"}]},{"@type":"WebSite","@id":"https:\/\/insurancecorp.com.br\/pt\/#website","url":"https:\/\/insurancecorp.com.br\/pt\/","name":"Revista Insurance Corp | PT-BR","description":"A \u00fanica revista bil\u00edngue voltada ao mercado de seguro.","publisher":{"@id":"https:\/\/insurancecorp.com.br\/pt\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/insurancecorp.com.br\/pt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/insurancecorp.com.br\/pt\/#organization","name":"Revista Insurance Corp","url":"https:\/\/insurancecorp.com.br\/pt\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/insurancecorp.com.br\/pt\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Revista Insurance Corp"},"image":{"@id":"https:\/\/insurancecorp.com.br\/pt\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RevistaInsuranceCorp\/"]},{"@type":"Person","@id":"https:\/\/insurancecorp.com.br\/pt\/#\/schema\/person\/1b69c8cf325f0b7167f1b171f52df4af","name":"Publica\u00e7\u00e3o","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/0a30cecf8e1b3673b68620de9f9a164e8f9cce0e15f8e36bcff0e4a33c0142e8?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/0a30cecf8e1b3673b68620de9f9a164e8f9cce0e15f8e36bcff0e4a33c0142e8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0a30cecf8e1b3673b68620de9f9a164e8f9cce0e15f8e36bcff0e4a33c0142e8?s=96&d=mm&r=g","caption":"Publica\u00e7\u00e3o"}}]}},"_links":{"self":[{"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/posts\/39562","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/comments?post=39562"}],"version-history":[{"count":3,"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/posts\/39562\/revisions"}],"predecessor-version":[{"id":39566,"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/posts\/39562\/revisions\/39566"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/media\/39564"}],"wp:attachment":[{"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/media?parent=39562"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/categories?post=39562"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/tags?post=39562"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}